Status:
TERMINATED
Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients
Lead Sponsor:
Stanford University
Conditions:
Blood Stem Cell Transplant Failure
Eligibility:
All Genders
Up to 21 years
Brief Summary
The aim of our study is to determine whether a clinically relevant laboratory measurement (of seven specific immunologic biochemicals in the blood) can identify which bone marrow transplant recipients...
Eligibility Criteria
Inclusion
- Inclusion Criteria:- Hematopoietic stem cell transplantation (HSCT) for any indication.
- Patients will range from age 0 to age 21. There is no gender restriction. We expect the male to female ratio to end up being about 50/50
- Ability to understand and the willingness to sign a written informed consent document.
Exclusion
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT01135355
Start Date
July 1 2008
End Date
January 1 2011
Last Update
June 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305